For example, a metabolomics study found that a combined panel of six markers—KYNA, QUIN, TRP, PIC, fibroblast growth factor, and TNF-α—could discriminate MS subtypes with up to ~85–91% sensitivity [58]. The gene discussed is TNF; the disease is myeloid sarcoma.